ViRexx Medical Corp.Memorandum of Amending Agreement • April 5th, 2007 • Virexx Medical Corp • Biological products, (no disgnostic substances) • Alberta
WHEREAS the Company and the Employee have entered into an Employment Agreement dated the 15th day of April, 2006 (the “Employment Agreement”);
EMPLOYMENT AGREEMENTEmployment Agreement • April 5th, 2007 • Virexx Medical Corp • Biological products, (no disgnostic substances) • Alberta
WHEREAS ViRexx carries on the business of a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of chronic hepatitis B, hepatitis C and selected solid tumors (hereinafter called the “Business”);
THIS AGREEMENT EFFECTIVE THE 1ST DAY OF NOVEMBER, 1999Agreement • April 5th, 2007 • Virexx Medical Corp • Biological products, (no disgnostic substances) • Alberta
SUBSCRIPTION FOR UNITS/SHARES (for foreign non-US purchasers) (Alberta Securities Commission Rule 72-501)Virexx Medical Corp • April 5th, 2007 • Biological products, (no disgnostic substances) • Alberta
Scott Langille Employment Agreement of April 15, 2006 Agreement Amendments of December 18, 2006Virexx Medical Corp • April 5th, 2007 • Biological products, (no disgnostic substances)
ViRexx Medical Corp.Memorandum of Amending Agreement • April 5th, 2007 • Virexx Medical Corp • Biological products, (no disgnostic substances) • Alberta
WHEREAS the Company and the Employee have entered into an Employment Agreement dated November 1, 2005 (the “Employment Agreement”);
EMPLOYMENT AGREEMENTAgreement • April 5th, 2007 • Virexx Medical Corp • Biological products, (no disgnostic substances) • Alberta
NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the mutual covenants and agreements referred to herein, and the sum of TEN DOLLARS ($10) now paid or to be paid on behalf of the Employer to the Employee, the receipt and sufficiency of which consideration is hereby acknowledged, the parties covenant and agree as follows:
